GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmena SA (WAR:PHR) » Definitions » Cyclically Adjusted PB Ratio

Pharmena (WAR:PHR) Cyclically Adjusted PB Ratio : 4.49 (As of Jun. 01, 2025)


View and export this data going back to 2008. Start your Free Trial

What is Pharmena Cyclically Adjusted PB Ratio?

As of today (2025-06-01), Pharmena's current share price is zł3.50. Pharmena's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2024 was zł0.78. Pharmena's Cyclically Adjusted PB Ratio for today is 4.49.

The historical rank and industry rank for Pharmena's Cyclically Adjusted PB Ratio or its related term are showing as below:

WAR:PHR' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 4.49   Med: 7.37   Max: 12.89
Current: 4.49

During the past years, Pharmena's highest Cyclically Adjusted PB Ratio was 12.89. The lowest was 4.49. And the median was 7.37.

WAR:PHR's Cyclically Adjusted PB Ratio is ranked worse than
79.32% of 672 companies
in the Biotechnology industry
Industry Median: 1.49 vs WAR:PHR: 4.49

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Pharmena's adjusted book value per share data for the three months ended in Sep. 2024 was zł1.055. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is zł0.78 for the trailing ten years ended in Sep. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pharmena Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Pharmena's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmena Cyclically Adjusted PB Ratio Chart

Pharmena Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 8.93 6.26 8.60

Pharmena Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.14 8.60 10.19 7.56 7.31

Competitive Comparison of Pharmena's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Pharmena's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmena's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmena's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pharmena's Cyclically Adjusted PB Ratio falls into.


;
;

Pharmena Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Pharmena's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=3.50/0.78
=4.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmena's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2024 is calculated as:

For example, Pharmena's adjusted Book Value per Share data for the three months ended in Sep. 2024 was:

Adj_Book=Book Value per Share/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=1.055/153.4391*153.4391
=1.055

Current CPI (Sep. 2024) = 153.4391.

Pharmena Quarterly Data

Book Value per Share CPI Adj_Book
201412 1.421 100.122 2.178
201503 1.361 100.041 2.087
201506 1.174 100.448 1.793
201509 1.168 99.634 1.799
201512 0.942 99.471 1.453
201603 0.791 98.983 1.226
201606 0.652 99.552 1.005
201609 0.658 99.064 1.019
201612 0.645 100.366 0.986
201703 0.578 101.018 0.878
201706 0.481 101.180 0.729
201709 0.444 101.343 0.672
201712 0.264 102.564 0.395
201803 0.458 102.564 0.685
201806 0.438 103.378 0.650
201809 0.438 103.378 0.650
201812 0.220 103.785 0.325
201903 0.164 104.274 0.241
201906 0.784 105.983 1.135
201909 0.670 105.983 0.970
201912 0.468 107.123 0.670
202003 0.362 109.076 0.509
202006 0.224 109.402 0.314
202009 0.159 109.320 0.223
202012 -0.013 109.565 -0.018
202103 -0.069 112.658 -0.094
202106 -0.239 113.960 -0.322
202109 -0.299 115.588 -0.397
202112 -0.437 119.088 -0.563
202203 -0.455 125.031 -0.558
202206 -0.505 131.705 -0.588
202209 3.988 135.531 4.515
202212 -0.583 139.113 -0.643
202303 -0.593 145.950 -0.623
202306 -0.640 147.009 -0.668
202309 2.061 146.113 2.164
202312 2.022 147.741 2.100
202403 2.043 149.044 2.103
202406 1.109 150.997 1.127
202409 1.055 153.439 1.055

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pharmena  (WAR:PHR) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Pharmena Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Pharmena's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmena Business Description

Industry
Traded in Other Exchanges
N/A
Address
Ulica Wolczanska 178, Lodz, POL, 90-530
Pharmena SA produces cosmeceuticals and pharmaceuticals. The company's activity focuses on three areas such as research in the USA and Canada on the application of selected pyridinium salts in medicine in order to develop an anti-atherosclerosis drug on a global scale, Production and sales of innovative patented dermocosmetics and introduction into the market of an innovative dietary supplement for atherosclerosis prophylaxis. Its products include Menavitin, Dermena, Allerco and Thermi.